Literature DB >> 22810955

-Omics and cancer biomarkers: link to the biological truth or bear the consequences.

Lance A Liotta, Emanuel F Petricoin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22810955      PMCID： PMC3761362          DOI： 10.1158/1055-9965.EPI-12-0635

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  38 in total

1.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

2.  Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.

Authors:  Lesleyann Hawthorn; Leighton Stein; Jenniffer Panzarella; Gregory M Loewen; Heinz Baumann
Journal:  Lung Cancer       Date:  2006-06-06       Impact factor: 5.705

3.  Laser-capture microdissection.

Authors:  Virginia Espina; Julia D Wulfkuhle; Valerie S Calvert; Amy VanMeter; Weidong Zhou; George Coukos; David H Geho; Emanuel F Petricoin; Lance A Liotta
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Progressive degradation of serum samples limits proteomic biomarker discovery.

Authors:  Shadab Ahmad; Elayanambi Sundaramoorthy; Reena Arora; Somdutta Sen; Ganesan Karthikeyan; Shantanu Sengupta
Journal:  Anal Biochem       Date:  2009-07-24       Impact factor: 3.365

5.  Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks.

Authors:  Timothy R Holzer; Angie D Fulford; Austin M Arkins; Janet M Grondin; Christopher W Mundy; Aejaz Nasir; Andrew E Schade
Journal:  Anticancer Res       Date:  2011-06       Impact factor: 2.480

6.  Bring on the biomarkers.

Authors:  George Poste
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

Review 7.  Phosphoproteomics in cancer.

Authors:  H C Harsha; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2010-09-26       Impact factor: 6.603

8.  Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization.

Authors:  C Bart Rountree; Colleen A Van Kirk; Hanning You; Wei Ding; Hien Dang; Heather D VanGuilder; Willard M Freeman
Journal:  Proteome Sci       Date:  2010-11-22       Impact factor: 2.480

9.  Active roles of tumor stroma in breast cancer metastasis.

Authors:  Zahraa I Khamis; Ziad J Sahab; Qing-Xiang Amy Sang
Journal:  Int J Breast Cancer       Date:  2012-02-19

10.  Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA.

Authors:  K Henare; L Wang; L-C S Wang; L Thomsen; S Tijono; C-J J Chen; S Winkler; P R Dunbar; C Print; L-M Ching
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640
View more
  7 in total

1.  Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.

Authors:  Stephanie Shao; Benjamin A Neely; Tzu-Cheg Kao; Janet Eckhaus; Jolie Bourgeois; Jasmin Brooks; Elizabeth E Jones; Richard R Drake; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-21       Impact factor: 4.254

Review 2.  Reverse phase protein arrays: mapping the path towards personalized medicine.

Authors:  Rosa I Gallagher; Virginia Espina
Journal:  Mol Diagn Ther       Date:  2014-12       Impact factor: 4.074

3.  PRSS3/mesotrypsin in prostate cancer progression: implications for translational medicine.

Authors:  Evette S Radisky
Journal:  Asian J Androl       Date:  2013-03-18       Impact factor: 3.285

4.  Translational cancer research: balancing prevention and treatment to combat cancer globally.

Authors:  Christopher P Wild; John R Bucher; Bas W D de Jong; Joakim Dillner; Christina von Gertten; John D Groopman; Zdenko Herceg; Elaine Holmes; Reetta Holmila; Jørgen H Olsen; Ulrik Ringborg; Augustin Scalbert; Tatsuhiro Shibata; Martyn T Smith; Cornelia Ulrich; Paolo Vineis; John McLaughlin
Journal:  J Natl Cancer Inst       Date:  2014-12-16       Impact factor: 13.506

5.  Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics.

Authors:  Frederik Großerueschkamp; Thilo Bracht; Hanna C Diehl; Claus Kuepper; Maike Ahrens; Angela Kallenbach-Thieltges; Axel Mosig; Martin Eisenacher; Katrin Marcus; Thomas Behrens; Thomas Brüning; Dirk Theegarten; Barbara Sitek; Klaus Gerwert
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

6.  An individualized gene expression signature for prediction of lung adenocarcinoma metastases.

Authors:  Lishuang Qi; Tianhao Li; Gengen Shi; Jiasheng Wang; Xin Li; Sainan Zhang; Libin Chen; Yuan Qin; Yunyan Gu; Wenyuan Zhao; Zheng Guo
Journal:  Mol Oncol       Date:  2017-10-10       Impact factor: 6.603

Review 7.  Proteogenomic convergence for understanding cancer pathways and networks.

Authors:  Emily S Boja; Henry Rodriguez
Journal:  Clin Proteomics       Date:  2014-06-01       Impact factor: 3.988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.